SQI Q4 Net Loss Jumps 50 Percent on Professional Fees | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SQI Diagnostics reported after the close of the market Wednesday that its fourth-quarter 2011 net loss climbed 50 percent on higher professional and consulting fees tied to an acquisition that was not completed and financings.

The Toronto-based microarray diagnostics firm reported revenues of C$5,000 (US$4,884) for the quarter ended Sept. 30, compared to C$14,000 for the fourth quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.